Cytek Biosciences, Inc.CTKBNASDAQ
Loading
P/E Ratio: Discounted ValuationCompressed
Percentile Rank50
Studio
Year-over-Year Change

Price-to-earnings ratio

Percentile
P50
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive growthCompressed
PeriodValueYoY Change
2025-9.70+93.1%
2024-140.81-38.6%
2023-101.56-119.1%
2022533.13-26.7%
2021727.36+465.9%
2020128.53+186.7%
2019-148.27-